BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 25926795)

  • 1. The therapeutic potential of orphan GPCRs, GPR35 and GPR55.
    Shore DM; Reggio PH
    Front Pharmacol; 2015; 6():69. PubMed ID: 25926795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
    Zhao P; Abood ME
    Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.
    Guo YJ; Zhou YJ; Yang XL; Shao ZM; Ou ZL
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1159-1167. PubMed ID: 28943434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Sharir H; Shore DM; Hurst DP; Lynch DL; Madrigal KE; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak LS; Croatt MP; Abood ME; Reggio PH
    Biochemistry; 2013 Dec; 52(52):9456-69. PubMed ID: 24274581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Non-CB
    Morales P; Reggio PH
    Cannabis Cannabinoid Res; 2017; 2(1):265-273. PubMed ID: 29098189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors.
    Irving A; Abdulrazzaq G; Chan SLF; Penman J; Harvey J; Alexander SPH
    Adv Pharmacol; 2017; 80():223-247. PubMed ID: 28826536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The orphan receptor GPR55 is a novel cannabinoid receptor.
    Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
    Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From orphan to oncogene: The role of GPR35 in cancer and immune modulation.
    Takkar S; Sharma G; Kaushal JB; Abdullah KM; Batra SK; Siddiqui JA
    Cytokine Growth Factor Rev; 2024 Jun; 77():56-66. PubMed ID: 38514303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of orphan G protein-coupled receptors in the modulation of pain: A review.
    Nourbakhsh F; Atabaki R; Roohbakhsh A
    Life Sci; 2018 Nov; 212():59-69. PubMed ID: 30236869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17.
    Maravillas-Montero JL; Burkhardt AM; Hevezi PA; Carnevale CD; Smit MJ; Zlotnik A
    J Immunol; 2015 Jan; 194(1):29-33. PubMed ID: 25411203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
    Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.
    Yao H; Lv Y; Bai X; Yu Z; Liu X
    Oncol Lett; 2020 Sep; 20(3):2711-2720. PubMed ID: 32782587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR35 mediates lodoxamide-induced migration inhibitory response but not CXCL17-induced migration stimulatory response in THP-1 cells; is GPR35 a receptor for CXCL17?
    Park SJ; Lee SJ; Nam SY; Im DS
    Br J Pharmacol; 2018 Jan; 175(1):154-161. PubMed ID: 29068046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR55: from orphan to metabolic regulator?
    Liu B; Song S; Jones PM; Persaud SJ
    Pharmacol Ther; 2015 Jan; 145():35-42. PubMed ID: 24972076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
    Sharir H; Abood ME
    Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.